Related Experiment Video
Updated: Oct 12, 2025

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
Published on: August 30, 2024
Cardiovascular Health in Pediatric Rheumatologic Diseases
Kaveh Ardalan1, Donald M Lloyd-Jones2, Laura E Schanberg3
1Department of Pediatrics, Division of Pediatric Rheumatology, Duke University School of Medicine, T909 Children's Health Center, DUMC Box 3212, Durham, NC 27710, USA; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago; Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago.
Insights
Children with rheumatic diseases like juvenile lupus face significant cardiovascular disease risk. Addressing inflammation and improving heart health through interventions is crucial for better long-term outcomes.
Area of Science:
- Pediatric Rheumatology
- Cardiovascular Health
- Public Health
Background:
- Children with juvenile systemic lupus erythematosus, juvenile dermatomyositis, and juvenile idiopathic arthritis exhibit increased cardiovascular disease risk.
- Cardiovascular health, defined by the American Heart Association, encompasses protective factors against heart disease.
- Chronic inflammation and endothelial dysfunction in rheumatic diseases contribute to elevated cardiovascular risk.
Purpose of the Study:
- To highlight the cardiovascular disease risk in pediatric rheumatic diseases.
- To emphasize the link between disease-related factors and cardiovascular health.
- To underscore the need for interventions to improve cardiovascular outcomes in affected children.
Main Methods:
- Literature review on cardiovascular risk in pediatric rheumatic diseases.
- Analysis of the relationship between inflammation, endothelial dysfunction, and cardiovascular health.
- Identification of gaps in current management strategies.
Main Results:
- Juvenile rheumatic diseases are associated with early-onset cardiovascular disease risk.
- Disease mechanisms directly and indirectly impair cardiovascular health.
- Existing research indicates a need for targeted cardiovascular interventions.
Conclusions:
- Children with juvenile idiopathic arthritis, juvenile dermatomyositis, and juvenile systemic lupus erythematosus require proactive cardiovascular risk management.
- Interventions targeting chronic inflammation and endothelial dysfunction are essential.
- Pharmacologic and nonpharmacologic strategies are needed to improve cardiovascular health and long-term outcomes in pediatric rheumatic diseases.
Abstract:
Cardiovascular disease risk is evident during childhood for patients with juvenile systemic lupus erythematosus, juvenile dermatomyositis, and juvenile idiopathic arthritis. The American Heart Association defines cardiovascular health as a positive health construct reflecting the sum of protective factors against cardiovascular disease. Disease-related factors such as chronic inflammation and endothelial dysfunction increase cardiovascular disease risk directly and through bidirectional relationships with poor cardiovascular health factors. Pharmacologic and nonpharmacologic interventions to improve cardiovascular health and long-term cardiovascular outcomes in children with rheumatic disease are needed.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease III: Medical Management
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Myocarditis III: Medical Management

